Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA.
Humberto C GonzalezYueren ZhouFaisal M NimriLoralee B RuppSheri TrudeauStuart C GordonPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
Early reports suggest that alcohol misuse increased in 2020 as a result of the COVID-19 pandemic. Using retrospective data from Henry Ford Health System in Detroit MI-an area that experienced an early and severe COVID-19 outbreak-we investigated the impact of the pandemic on alcohol-related liver disease (ARLD) in the summer of 2020 compared with the same period in 2016-2019. Both the number of ARLD admissions and the proportion of total admissions represented by ARLD patients increased significantly in 2020 compared with previous years. The number of ARLD admissions as a proportion of all hospitalizations was 50% higher in 2020 than in 2016-2019 (0.31% vs 0.21%; P = .0013); by September 2020, the number of admissions was 66% higher than previous years. Despite racial and geographical disparities in direct and indirect COVID-related stressors across the Detroit metropolitan area, the demographic profile of ARLD patients did not change compared with previous years.
Keyphrases
- end stage renal disease
- coronavirus disease
- sars cov
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- prognostic factors
- emergency department
- healthcare
- high resolution
- chronic pain
- machine learning
- alcohol consumption
- cross sectional
- early onset
- health insurance
- artificial intelligence
- single molecule
- respiratory syndrome coronavirus